Alterity Therapeutics Limited (ATHE) Stock Price

3.78 ▲ +0.271 (+7.72%)
Open: 3.48 Vol: 24.9K Day's range: 3.48 - 3.78 Nov 26, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ATHE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 3.70▲ 3.70▲ 3.70▲ 3.57▲ 3.76▲
MA10 3.76▲ 3.85▼ 3.85▼ 3.64▲ 4.07▼
MA20 4.25▼ 4.31▼ 4.31▼ 3.75▲ 4.62▼
MA50 4.67▼ 4.65▼ 4.57▼ 4.17▼ 4.16▼
MA100 4.73▼ 4.48▼ 4.47▼ 4.60▼ 2.94▲
MA200 4.54▼ 4.78▼ 4.85▼ 4.25▼ 3.65▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.043▼ -0.067▼ -0.072▼ 0.016▲ -0.175▼
RSI 32.685▼ 33.169▼ 33.927▼ 46.585▼ 45.634▼
STOCH 12.260▼ 9.959▼ 9.959▼ 28.381     20.498    
WILL %R -85.892▼ -85.892▼ -85.892▼ -22.547▲ -82.781▼
CCI -40.759     -49.006     -49.006     25.506     -98.023    
Latest Filters Detected On ATHE
▲ MACD $ATHE MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $ATHE Price Crossed Above MA(13) Set Alert
MA $ATHE Price Crossed Above MA(7) Set Alert
CDL $ATHE Engulfing Candlestick Pattern Detected Set Alert
CDL $ATHE Marubozu Candlestick Pattern Detected Set Alert
Alterity Therapeutics Limited News
Alterity Therapeutics Discloses Equity Derivative Positions
Wednesday, November 12, 2025 08:48 PM
Alterity Therapeutics Limited has disclosed a notice from Regal Funds Management Asia Pte Limited in compliance with the Australian Takeovers Panel Guidance Note 20 on Equity Derivatives. This ...
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
Wednesday, November 12, 2025 03:25 AM
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments ...
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous ...
Sunday, November 09, 2025 11:25 PM
– Data highlights symptom stability and enhanced efficacy signals in higher dose group – – Analysis offers valuable insights to guide ongoing development and planning of Phase 3 – MELBOURNE, Australia ...
ATHE historical stock data
date open high low close volume
26/11/25 3.48 3.78 3.48 3.78 24,898
25/11/25 3.66 3.66 3.47 3.509 12,518
24/11/25 3.53 3.61 3.52 3.55 4,004
21/11/25 3.49 3.61 3.4887 3.51 1,950
20/11/25 3.51 3.7499 3.47 3.52 9,491
19/11/25 3.6511 3.78 3.595 3.63 7,394
18/11/25 3.55 3.6955 3.5212 3.60 18,505
17/11/25 3.79 3.8596 3.67 3.7942 5,208
14/11/25 3.7526 3.8896 3.75 3.84 15,471
13/11/25 3.77 3.77 3.56 3.69 7,724
Quote Details
52wk Low:1.41
52wk High:7.00
Vol:24.9K
Avg Vol(3m):1.9M
1Y Chng:+66.52%
1M Chng:-21.74%
Add to Watch List
More Information
Index US Composite
Market Cap. 68.52M